These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 70585)

  • 21. Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. A multicenter double-blind trial. Tokyo Cooperative Gallstone Study Group.
    Gastroenterology; 1980 Mar; 78(3):542-8. PubMed ID: 6985882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gall stone dissolving agents.
    Bouchier IA
    Br Med J (Clin Res Ed); 1983 Mar; 286(6367):778-80. PubMed ID: 6402249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones.
    Meredith TJ; Williams GV; Maton PN; Murphy GM; Saxton HM; Dowling RH
    Gut; 1982 May; 23(5):382-9. PubMed ID: 7076015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A combination therapy with simvastatin and ursodeoxycholic acid is more effective for cholesterol gallstone dissolution than is ursodeoxycholic acid monotherapy.
    Tazuma S; Kajiyama G; Mizuno T; Yamashita G; Miura H; Kajihara T; Hattori Y; Miyake H; Nishioka T; Hyogo H; Sunami Y; Yasumiba S; Ochi H; Matsumoto T; Abe A; Adachi K; Omata F; Ueno F; Sugata F; Ohguri S; Shibata H; Kokubu S
    J Clin Gastroenterol; 1998 Jun; 26(4):287-91. PubMed ID: 9649013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lovastatin added to ursodeoxycholic acid further reduces biliary cholesterol saturation.
    Logan GM; Duane WC
    Gastroenterology; 1990 Jun; 98(6):1572-6. PubMed ID: 2338194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of diet on dissolution of gallstones by ursodeoxycholic acid, including a comparison between ultrasonography and cholecystography.
    Lefkof IR; Frenkiel PG; Lee DW; Cohen H; Bonorris GG; Gilmore CJ; Hamlin JA; Komaiko M; Resser K; Marks JW
    Mt Sinai J Med; 1986 Apr; 53(4):241-9. PubMed ID: 3014318
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones.
    Thistle JL; Hofmann AF
    N Engl J Med; 1973 Sep; 289(13):655-9. PubMed ID: 4580472
    [No Abstract]   [Full Text] [Related]  

  • 28. Relationships between squalene and cholesterol in bile: effect of ursodeoxycholic acid administration in patients with radiolucent gallstones.
    Salvioli G; Lugli R; Pradelli JM
    Metabolism; 1984 Jul; 33(7):641-5. PubMed ID: 6738365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
    von Bergmann K; Epple-Gutsfeld M; Leiss O
    Gastroenterology; 1984 Jul; 87(1):136-43. PubMed ID: 6724256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dissolution of gallstones based on 6 months treatment with a single daily dose of ursodeoxycholic acid].
    Realini S; Gonvers JJ; Arnold J; Borel GA; Bretholz A; Capitaine Y; Hofstetter JR; Bettini L; di Simone A
    Schweiz Med Wochenschr; 1983 Apr; 113(17):641-2. PubMed ID: 6867654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight.
    Broomfield PH; Chopra R; Sheinbaum RC; Bonorris GG; Silverman A; Schoenfield LJ; Marks JW
    N Engl J Med; 1988 Dec; 319(24):1567-72. PubMed ID: 3200265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral dissolution of gallstones.
    Zuccaro G
    Cleve Clin J Med; 1988; 55(6):497-8. PubMed ID: 3228973
    [No Abstract]   [Full Text] [Related]  

  • 33. [Ursodeoxycholic acid in the treatment of gallbladder lithiasis].
    Mamianetti A; Labonia NA; Lafont D; Fiordalisi HH
    Acta Gastroenterol Latinoam; 1982; 12(1):33-8. PubMed ID: 7136453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of diet on bile acid kinetics and biliary lipid secretion in gallstone patients treated with ursodeoxycholic acid.
    Frenkiel PG; Lee DW; Cohen H; Gilmore CJ; Resser K; Bonorris GG; Marks JW; Schoenfield LJ
    Am J Clin Nutr; 1986 Feb; 43(2):239-50. PubMed ID: 3004189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of different doses of chenodeoxycholic acid on bile-lipid composition and on frequency of side-effects in patients with gallstones.
    Mok HY; Bell GD; Dowling RH
    Lancet; 1974 Aug; 2(7875):253-7. PubMed ID: 4135688
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of response to chenodeoxycholic acid in obese and non-obese patients. Role of cholesterol synthesis and possible response to ursodeoxycholic acid.
    Maton PN; Murphy GM; Dowling RH
    Gut; 1980 Dec; 21(12):1082-6. PubMed ID: 7461467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of gallstone with ursodeoxycholic acid--lipid and bile acid composition in bile (author's transl)].
    Tanikawa K; Maeyama T; Abe H; Anno H; Okumura M; Chuman Y; Koji T; Nakagawa S; Nakamura Y; Iino H; Yamasaki S; Hisatsugu T
    Nihon Shokakibyo Gakkai Zasshi; 1978 Aug; 75(8):1196-203. PubMed ID: 722960
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
    Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study.
    Leuschner U; Leuschner M; Sieratzki J; Kurtz W; Hübner K
    Dig Dis Sci; 1985 Jul; 30(7):642-9. PubMed ID: 4006646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral dissolution therapy for cholelithiasis: mix and match.
    Phillips RS; Barkin JS
    Am J Gastroenterol; 1990 Nov; 85(11):1532-3. PubMed ID: 2239886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.